Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants

Clinical trial NCT06566092 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06566092
Sponsor: Iovance Biotherapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Soft Tissue Sarcoma Primary Central Nervous System Carcinoma Melanoma Rhabdomyosarcoma Ewing Sarcoma

Start date: 2024-03-28
Primary completion: 2026-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.